How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Diasorin Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
70 clearance records and 39 recall records in the covered releases, across 1 source company names and 50 product codes. Dated history runs from Nov 16, 1998 to Jun 4, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 1 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteXK260770 · LOM | DiaSorin, Inc. | 510(k) | Jun 4, 2026FDA decision date |
| DiaSorin LIAISON Q.S.E.T. Device Plus, REF 319060; intended for use in the preparation of human stool specimensZ-0677-2025 · NXO | Diasorin Inc. | Recall | Dec 12, 2024FDA classification date |
| DiaSorin LIAISON HSV-2 Type Specific IgG, REF 310620Z-0815-2024 · MYF | Diasorin Inc. | Recall | Jan 25, 2024FDA classification date |
| LIAISON VZV IgG HT, LIAISON Control VZV IgG HTK231214 · LFY | DiaSorin, Inc. | 510(k) | Oct 27, 2023FDA decision date |
| LIAISON Anti-HAV; LIAISON XSK223403 · LOL | DiaSorin, Inc. | 510(k) | Dec 9, 2022FDA decision date |
| LIAISON Calprotectin, LIAISON Q.S.E.T. Device PlusK213858 · NXO | DiaSorin, Inc. | 510(k) | Jul 26, 2022FDA decision date |
| LIAISON MeMed BV, LIAISON MeMed BV Control SetK213936 · QPS | DiaSorin, Inc. | 510(k) | Jul 14, 2022FDA decision date |
| LIAISON FerritinK193650 · DBF | DiaSorin, Inc. | 510(k) | Sep 14, 2021FDA decision date |
| LIAISON 1-84 PTH Assay - Product Usage: is an in vitro chemiluminescent immunoassay (CLIA) intended for the quantitative determination of parathy…Z-1342-2021 · CEW | Diasorin Inc. | Recall | Apr 1, 2021FDA record creation date |
| LIAISON Lyme IgM, LIAISON Lyme IgM Control Set, LIAISON Lyme Total Antibody PlusK202573 · LSR | DiaSorin, Inc. | 510(k) | Feb 18, 2021FDA decision date |
| LIAISON Lyme IgG, LIAISON Lyme IgG Control Set, LIAISON Lyme Total Antibody PlusK202574 · LSR | DiaSorin, Inc. | 510(k) | Feb 18, 2021FDA decision date |
| LIAISON Anti-HAVK210272 · LOL | DiaSorin, Inc. | 510(k) | Feb 9, 2021FDA decision date |
| LIAISON Testosterone xtK201908 · CDZ | DiaSorin, Inc. | 510(k) | Oct 15, 2020FDA decision date |
| Parvovirus B19 IgG EIA kit Part No. V519IGUSZ-2936-2020 · MYL | Diasorin Inc. | Recall | Sep 3, 2020FDA record creation date |
| LIAISON® FolateK192586 · CGN | DiaSorin, Inc. | 510(k) | May 6, 2020FDA decision date |
| LIAISON Anti-HAV AssayK193532 · LOL | DiaSorin, Inc. | 510(k) | Mar 2, 2020FDA decision date |
| LIAISON Lyme Total Antibody Plus, LIAISON Lyme Total Antibody Plus Control SetK193051 · LSR | DiaSorin, Inc. | 510(k) | Jan 29, 2020FDA decision date |
| LIAISON XL Zika Capture IgM II and LIAISON XL Zika Capture IgM II Control SetK192046 · QFO | DiaSorin, Inc. | 510(k) | Oct 28, 2019FDA decision date |
| LIAISON Vitamin B12K192064 · CDD | DiaSorin, Inc. | 510(k) | Oct 2, 2019FDA decision date |
| LIAISON Calprotectin, LIAISON Calprotectin Control Set, LIAISON Calprotectin Calibration Verifiers, LIAISON Q.S.E.T. Buffer, LIAISON Q.S.E.T. Dev…K182698 · NXO | DiaSorin, Inc. | 510(k) | Dec 26, 2018FDA decision date |
| LIAISON Helicobacter Antigen, LIAISON Helicobacter Antigen Control SetK181464 · LYR | DiaSorin, Inc. | 510(k) | Aug 31, 2018FDA decision date |
| LIAISON BRAHMS PCT II GEN, LIAISON Control BRAHMS PCT II GEN, LIAISON BRAHMS PCT II GEN VerifiersK173683 · PRI | DiaSorin, Inc. | 510(k) | Feb 27, 2018FDA decision date |
| LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control SetK162969 · LFZ | DiaSorin, Inc. | 510(k) | Jan 6, 2017FDA decision date |
| LIAISON® VCA IgG and LIAISON® VCA IgG Serum Control Set; LIAISON® EBNA IgG and LIAISON® EBNA IgG Serum Control SetK162961 · LSE | DiaSorin, Inc. | 510(k) | Jan 5, 2017FDA decision date |
| LIAISON® EA IgG and LIAISON® EA IgG Serum Control SetK162959 · LSE | DiaSorin, Inc. | 510(k) | Jan 4, 2017FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.